In this study, we demonstrated for the first time that in a rat model of DN, a vaccine targeting AT1R named ATRQβ-001 attenuated the progression of the disease, as exhibited by reduction of biochemical parameters of renal dysfunction and amelioration of renal pathological changes. The gene discussed is AGTR1; the disease is liver dysplastic nodule.